Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 9 | 2025 | 261 | 3.080 |
Why?
|
| Brain Ischemia | 4 | 2025 | 87 | 2.170 |
Why?
|
| Metabolomics | 4 | 2025 | 87 | 1.020 |
Why?
|
| Metabolome | 2 | 2025 | 68 | 0.910 |
Why?
|
| Amino Acids | 2 | 2022 | 85 | 0.780 |
Why?
|
| Brain | 3 | 2025 | 770 | 0.730 |
Why?
|
| Hydrocephalus | 1 | 2022 | 55 | 0.700 |
Why?
|
| Biomarkers | 7 | 2025 | 777 | 0.700 |
Why?
|
| Hyperglycemia | 1 | 2022 | 78 | 0.690 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 63 | 0.680 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 122 | 0.640 |
Why?
|
| Pilot Projects | 4 | 2023 | 463 | 0.620 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 841 | 0.580 |
Why?
|
| Longitudinal Studies | 3 | 2025 | 429 | 0.520 |
Why?
|
| Humans | 18 | 2025 | 28870 | 0.410 |
Why?
|
| Puerperal Disorders | 1 | 2011 | 14 | 0.350 |
Why?
|
| Middle Aged | 11 | 2025 | 7415 | 0.340 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 485 | 0.330 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 112 | 0.320 |
Why?
|
| Aged | 9 | 2025 | 5598 | 0.290 |
Why?
|
| Retrospective Studies | 4 | 2022 | 2635 | 0.280 |
Why?
|
| Female | 12 | 2025 | 15631 | 0.270 |
Why?
|
| Autonomic Dysreflexia | 1 | 2007 | 1 | 0.270 |
Why?
|
| Hypotension, Orthostatic | 1 | 2007 | 8 | 0.260 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2025 | 180 | 0.260 |
Why?
|
| Male | 11 | 2025 | 13931 | 0.260 |
Why?
|
| Cerebral Hemorrhage | 2 | 2022 | 93 | 0.260 |
Why?
|
| Prospective Studies | 2 | 2020 | 1280 | 0.250 |
Why?
|
| Spinal Cord Injuries | 1 | 2007 | 69 | 0.250 |
Why?
|
| Autonomic Nervous System | 1 | 2007 | 118 | 0.240 |
Why?
|
| Prognosis | 4 | 2020 | 811 | 0.230 |
Why?
|
| Stroke Rehabilitation | 1 | 2025 | 14 | 0.230 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2025 | 16 | 0.230 |
Why?
|
| Spinal Cord | 1 | 2007 | 214 | 0.230 |
Why?
|
| Chromatography, Liquid | 1 | 2025 | 79 | 0.220 |
Why?
|
| Acute Disease | 2 | 2020 | 155 | 0.220 |
Why?
|
| Feedback, Sensory | 1 | 2024 | 4 | 0.220 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2024 | 14 | 0.220 |
Why?
|
| Somatosensory Cortex | 1 | 2024 | 17 | 0.220 |
Why?
|
| Electroencephalography | 1 | 2025 | 143 | 0.210 |
Why?
|
| Mass Spectrometry | 1 | 2025 | 196 | 0.210 |
Why?
|
| Cerebral Infarction | 2 | 2020 | 26 | 0.210 |
Why?
|
| Alanine | 1 | 2023 | 40 | 0.200 |
Why?
|
| Zebrafish | 1 | 2024 | 96 | 0.200 |
Why?
|
| Blood Volume | 1 | 2022 | 8 | 0.180 |
Why?
|
| Sphingolipids | 1 | 2022 | 20 | 0.180 |
Why?
|
| Apolipoprotein C-III | 1 | 2021 | 12 | 0.180 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 995 | 0.180 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2021 | 36 | 0.170 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 102 | 0.170 |
Why?
|
| Thrombolytic Therapy | 1 | 2021 | 41 | 0.170 |
Why?
|
| Brain Infarction | 1 | 2020 | 10 | 0.170 |
Why?
|
| Fibrinolytic Agents | 1 | 2021 | 72 | 0.170 |
Why?
|
| Glucaric Acid | 1 | 2020 | 10 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 344 | 0.160 |
Why?
|
| Genetic Variation | 1 | 2021 | 246 | 0.160 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2019 | 4 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 381 | 0.160 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 379 | 0.160 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2019 | 16 | 0.160 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 100 | 0.160 |
Why?
|
| Thrombectomy | 1 | 2019 | 30 | 0.160 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 33 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 220 | 0.150 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 74 | 0.150 |
Why?
|
| Chronic Disease | 1 | 2020 | 274 | 0.150 |
Why?
|
| Treatment Outcome | 3 | 2021 | 2426 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 215 | 0.130 |
Why?
|
| Platelet Count | 1 | 2017 | 111 | 0.130 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 59 | 0.130 |
Why?
|
| Adult | 5 | 2025 | 8026 | 0.090 |
Why?
|
| Tangier Disease | 1 | 2011 | 1 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 481 | 0.090 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2011 | 6 | 0.090 |
Why?
|
| Eclampsia | 1 | 2011 | 5 | 0.090 |
Why?
|
| Vasospasm, Intracranial | 1 | 2011 | 18 | 0.090 |
Why?
|
| Pre-Eclampsia | 1 | 2011 | 49 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 98 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2011 | 916 | 0.070 |
Why?
|
| Animals | 3 | 2024 | 10699 | 0.070 |
Why?
|
| Pregnancy | 1 | 2011 | 1255 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2007 | 54 | 0.060 |
Why?
|
| Injury Severity Score | 1 | 2007 | 131 | 0.060 |
Why?
|
| Thoracic Vertebrae | 1 | 2007 | 70 | 0.060 |
Why?
|
| Cervical Vertebrae | 1 | 2007 | 123 | 0.060 |
Why?
|
| Prevalence | 1 | 2007 | 518 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2007 | 897 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2025 | 123 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2024 | 71 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 2065 | 0.050 |
Why?
|
| Movement | 1 | 2024 | 100 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2023 | 10 | 0.050 |
Why?
|
| Mutation | 2 | 2021 | 867 | 0.050 |
Why?
|
| United Kingdom | 1 | 2023 | 78 | 0.050 |
Why?
|
| Spinal Stenosis | 1 | 2003 | 15 | 0.050 |
Why?
|
| Time Factors | 1 | 2007 | 1613 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2024 | 310 | 0.050 |
Why?
|
| Exosomes | 1 | 2024 | 96 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 11 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 555 | 0.040 |
Why?
|
| Heterozygote | 1 | 2021 | 69 | 0.040 |
Why?
|
| Europe | 1 | 2021 | 99 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 115 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 138 | 0.040 |
Why?
|
| India | 1 | 2021 | 147 | 0.040 |
Why?
|
| Triglycerides | 1 | 2021 | 123 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 676 | 0.040 |
Why?
|
| Alleles | 1 | 2021 | 354 | 0.040 |
Why?
|
| Perfusion | 1 | 2020 | 43 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2020 | 37 | 0.040 |
Why?
|
| Necrosis | 1 | 2020 | 85 | 0.040 |
Why?
|
| Genotype | 1 | 2021 | 461 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 377 | 0.040 |
Why?
|
| Carotid Artery, Internal | 1 | 2019 | 19 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2019 | 54 | 0.040 |
Why?
|
| Adolescent | 1 | 2007 | 3194 | 0.040 |
Why?
|
| Neutrophils | 1 | 2020 | 185 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 381 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 169 | 0.040 |
Why?
|
| Cytokines | 1 | 2020 | 451 | 0.040 |
Why?
|
| Sex Factors | 1 | 2019 | 467 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 737 | 0.030 |
Why?
|
| Thrombosis | 1 | 2017 | 150 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1508 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 431 | 0.030 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2011 | 11 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 22 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 45 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2011 | 38 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 38 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 326 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 2835 | 0.020 |
Why?
|
| Lumbosacral Region | 1 | 2003 | 22 | 0.010 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2003 | 9 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 2003 | 81 | 0.010 |
Why?
|